Recent Finacing
Recent Raise
Annaida Technologies develops a non‑invasive, μNMR-based device for rapid, on-site quantitative viability assessment of sub-millimeter embryos for IVF, with applications in biochemical research and pharmacology.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Annaida Technologies.
